These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1216 related articles for article (PubMed ID: 34203002)
21. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease. Wasilewski A; Zielińska M; Storr M; Fichna J Inflamm Bowel Dis; 2015 Jul; 21(7):1674-82. PubMed ID: 25822014 [TBL] [Abstract][Full Text] [Related]
22. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics. Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670 [TBL] [Abstract][Full Text] [Related]
23. Probiotics and irritable bowel syndrome. Dai C; Zheng CQ; Jiang M; Ma XY; Jiang LJ World J Gastroenterol; 2013 Sep; 19(36):5973-80. PubMed ID: 24106397 [TBL] [Abstract][Full Text] [Related]
24. The Intestinal Microbiota and Irritable Bowel Syndrome. Ringel Y; Ringel-Kulka T J Clin Gastroenterol; 2015; 49 Suppl 1():S56-9. PubMed ID: 26447966 [TBL] [Abstract][Full Text] [Related]
25. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Markowiak P; Śliżewska K Nutrients; 2017 Sep; 9(9):. PubMed ID: 28914794 [TBL] [Abstract][Full Text] [Related]
26. Gut Microbiota and Chronic Constipation: A Review and Update. Ohkusa T; Koido S; Nishikawa Y; Sato N Front Med (Lausanne); 2019; 6():19. PubMed ID: 30809523 [No Abstract] [Full Text] [Related]
27. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Patel R; DuPont HL Clin Infect Dis; 2015 May; 60 Suppl 2(Suppl 2):S108-21. PubMed ID: 25922396 [TBL] [Abstract][Full Text] [Related]
28. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG). Barbuti RC; Schiavon LL; Oliveira CP; Alvares-DA-Silva MR; Sassaki LY; Passos MDCF; Farias AQ; Barros LL; Barreto BP; Albuquerque GBML; Alves AM; Navarro-Rodriguez T; Bittencourt PL Arq Gastroenterol; 2020; 57(4):381-398. PubMed ID: 33331485 [TBL] [Abstract][Full Text] [Related]
29. Probiotics, prebiotics, antibiotic, Chinese herbal medicine, and fecal microbiota transplantation in irritable bowel syndrome: Protocol for a systematic review and network meta-analysis. He Y; Xu R; Wang W; Zhang J; Hu X Medicine (Baltimore); 2020 Aug; 99(32):e21502. PubMed ID: 32769886 [TBL] [Abstract][Full Text] [Related]
30. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts. da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153 [TBL] [Abstract][Full Text] [Related]
31. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Dupont HL Aliment Pharmacol Ther; 2014 May; 39(10):1033-42. PubMed ID: 24665829 [TBL] [Abstract][Full Text] [Related]
32. Probiotics, prebiotics, and synbiotics regulate the intestinal microbiota differentially and restore the relative abundance of specific gut microorganisms. Li C; Niu Z; Zou M; Liu S; Wang M; Gu X; Lu H; Tian H; Jha R J Dairy Sci; 2020 Jul; 103(7):5816-5829. PubMed ID: 32418689 [TBL] [Abstract][Full Text] [Related]
33. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use. Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517 [TBL] [Abstract][Full Text] [Related]
34. Prebiotics, probiotics, synbiotics and postbiotics to adolescents in metabolic syndrome. Luzzi A; Briata IM; Di Napoli I; Giugliano S; Di Sabatino A; Rescigno M; Cena H Clin Nutr; 2024 Jun; 43(6):1433-1446. PubMed ID: 38704983 [TBL] [Abstract][Full Text] [Related]
35. The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis. Bock PM; Telo GH; Ramalho R; Sbaraini M; Leivas G; Martins AF; Schaan BD Diabetologia; 2021 Jan; 64(1):26-41. PubMed ID: 33047170 [TBL] [Abstract][Full Text] [Related]
36. Irritable bowel syndrome: a gut microbiota-related disorder? Bhattarai Y; Muniz Pedrogo DA; Kashyap PC Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G52-G62. PubMed ID: 27881403 [TBL] [Abstract][Full Text] [Related]
37. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. Lee KN; Lee OY World J Gastroenterol; 2014 Jul; 20(27):8886-97. PubMed ID: 25083061 [TBL] [Abstract][Full Text] [Related]
38. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Bonfrate L; Tack J; Grattagliano I; Cuomo R; Portincasa P Scand J Gastroenterol; 2013 Sep; 48(9):995-1009. PubMed ID: 23964766 [TBL] [Abstract][Full Text] [Related]
39. Microbiota shaping - the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: A systematic review. Baldi S; Mundula T; Nannini G; Amedei A World J Gastroenterol; 2021 Oct; 27(39):6715-6732. PubMed ID: 34754163 [TBL] [Abstract][Full Text] [Related]
40. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Simrén M; Barbara G; Flint HJ; Spiegel BM; Spiller RC; Vanner S; Verdu EF; Whorwell PJ; Zoetendal EG; Gut; 2013 Jan; 62(1):159-76. PubMed ID: 22730468 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]